Effects of Different Administration Protocols on the Plasma Concentration of Donepezil Hydrochloride in Dementia Patients with Stage 5 Chronic Kidney Disease

The prevalence of chronic kidney disease (CKD) as well as Alzheimer's disease (AD) increases with age. With the aging of the population in Japan, there is an increasing likelihood that patients with CKD will receive donepezil hydrochloride (DPZ), an antidementia drug, in the near future. Nevert...

Descripción completa

Detalles Bibliográficos
Autores principales: Amano, Chika, Ito, Takafumi, Egawa, Masahiro, Oka, Tomohiro, Hanada, Ken, Matsui, Kosuke, Nabika, Toru, Tanabe, Kazuaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710997/
https://www.ncbi.nlm.nih.gov/pubmed/23898347
http://dx.doi.org/10.1159/000351434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3710997/
https://www.ncbi.nlm.nih.gov/pubmed/23898347
http://dx.doi.org/10.1159/000351434

Ejemplares similares